1. Home
  2. ESOA vs ACRS Comparison

ESOA vs ACRS Comparison

Compare ESOA & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESOA
  • ACRS
  • Stock Information
  • Founded
  • ESOA 2006
  • ACRS 2012
  • Country
  • ESOA United States
  • ACRS United States
  • Employees
  • ESOA N/A
  • ACRS N/A
  • Industry
  • ESOA Water Sewer Pipeline Comm & Power Line Construction
  • ACRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESOA Industrials
  • ACRS Health Care
  • Exchange
  • ESOA Nasdaq
  • ACRS Nasdaq
  • Market Cap
  • ESOA 176.9M
  • ACRS 165.7M
  • IPO Year
  • ESOA 2006
  • ACRS 2015
  • Fundamental
  • Price
  • ESOA $9.84
  • ACRS $1.54
  • Analyst Decision
  • ESOA Strong Buy
  • ACRS Strong Buy
  • Analyst Count
  • ESOA 1
  • ACRS 8
  • Target Price
  • ESOA $21.00
  • ACRS $9.71
  • AVG Volume (30 Days)
  • ESOA 281.9K
  • ACRS 1.2M
  • Earning Date
  • ESOA 08-11-2025
  • ACRS 08-06-2025
  • Dividend Yield
  • ESOA 1.12%
  • ACRS N/A
  • EPS Growth
  • ESOA 81.20
  • ACRS N/A
  • EPS
  • ESOA 1.09
  • ACRS N/A
  • Revenue
  • ESOA $367,911,284.00
  • ACRS $17,777,000.00
  • Revenue This Year
  • ESOA $9.46
  • ACRS N/A
  • Revenue Next Year
  • ESOA $6.96
  • ACRS $11.77
  • P/E Ratio
  • ESOA $9.52
  • ACRS N/A
  • Revenue Growth
  • ESOA 4.62
  • ACRS N/A
  • 52 Week Low
  • ESOA $6.50
  • ACRS $1.05
  • 52 Week High
  • ESOA $19.83
  • ACRS $5.17
  • Technical
  • Relative Strength Index (RSI)
  • ESOA 55.48
  • ACRS 56.67
  • Support Level
  • ESOA $10.08
  • ACRS $1.44
  • Resistance Level
  • ESOA $10.86
  • ACRS $1.52
  • Average True Range (ATR)
  • ESOA 0.53
  • ACRS 0.10
  • MACD
  • ESOA 0.05
  • ACRS -0.00
  • Stochastic Oscillator
  • ESOA 79.17
  • ACRS 63.14

About ESOA Energy Services of America Corporation

Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: